Advertisement

Zolpidem Tartrate Immediate Release Tablets

[10 November 2016]

Products Affected - Description

Zolpidem Tartrate immediate release tablet, Aurobindo
5 mg, 500 count (NDC 65862-0159-05)
10 mg, 100 count (NDC 65862-0160-01)
10 mg, 500 count (NDC 65862-0160-05)

Reason for the Shortage

  • Aurobindo has all presentations listed as inactive.
  • Major discontinued zolpidem tartrate immediate release tablets.
  • Mylan has most zolpidem presentations available.
  • Sandoz has zolpidem available.
  • Torrent has zolpidem available.
  • Sanofi-Aventis has Ambien available.

Available Products

Ambien immediate release tablet, Sanofi-Aventis
10 mg, 100 count (NDC 00024-5421-31)
10 mg, 500 count (NDC 00024-5421-50)
 
Zolpidem Tartrate immediate release tablet, Mylan
5 mg, 100 count (NDC 00378-5305-01)
5 mg, 500 count (NDC 00378-5305-05)
10 mg, 100 count (NDC 00378-5310-01)
10 mg, 500 count (NDC 00378-5310-05)
 
Zolpidem Tartrate immediate release tablet, Mylan Institutional
5 mg, unit-dose 100 count (NDC 51079-0724-20)
10 mg, unit-dose 100 count (NDC 51079-0725-20)
 
Zolpidem Tartrate immediate release tablet, Sandoz
5 mg, 100 count (NDC 00781-5317-01)
5 mg, 500 count (NDC 00781-5317-10)
10 mg, 100 count (NDC 00781-5318-01)
10 mg, 500 count (NDC 00781-5318-10)
 
Zolpidem Tartrate immediate release tablet, Teva
5 mg, 100 count (NDC 00093-0073-01)
10 mg, 100 count (NDC 00093-0074-01)
 
Zolpidem Tartrate immediate release tablet, Torrent
5 mg, 100 count (NDC 13668-0007-01)
5 mg, 500 count (NDC 13668-0007-05)
5 mg, 1000 count (NDC 13668-0007-10)
5 mg, 1500 count (NDC 13668-0007-15)
10 mg, 100 count (NDC 13668-0008-01)
10 mg, 500 count (NDC 13668-0008-05)
10 mg, 1000 count (NDC 13668-0008-10)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages

Updated

November 10, September 27, July 28, June 27, 9 and 1, May 3, April 7, February 25, 5 and 1, 2016; December 28 and 10, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing